Moreover, in a manner dependent on the transcription factors c-MYC and PGC1α treatment with Aurora kinase A inhibitors renders GBM cells highly oxidative and dependent on fatty acid oxidation that in turn mediates them to be susceptible to inhibitors of FAO in vitro and in vivo. Here, PPARGC1A is linked to glioblastoma.